loadpatents
Patent applications and USPTO patent grants for Yates-Binder; Cecelia C..The latest application filed is for "small peptide compositions and uses thereof".
Patent | Date |
---|---|
Small Peptide Compositions And Uses Thereof App 20220257718 - Yates-Binder; Cecelia C. ;   et al. | 2022-08-18 |
Activators of CXCR3 for the treatment of angiopathies of the eye Grant 11,406,687 - Wells , et al. August 9, 2 | 2022-08-09 |
Small peptide compositions and uses thereof Grant 11,338,017 - Yates-Binder , et al. May 24, 2 | 2022-05-24 |
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye App 20210000919 - Wells; Alan H. ;   et al. | 2021-01-07 |
Goblet cell replacement therapy Grant 10,561,710 - Yates-Binder , et al. Feb | 2020-02-18 |
Small Peptide Compositions And Uses Thereof App 20190298802 - Yates-Binder; Cecelia C. ;   et al. | 2019-10-03 |
Goblet Cell Replacement Therapy App 20180333460 - Yates-Binder; Cecelia C. ;   et al. | 2018-11-22 |
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye App 20180280478 - Wells; Alan H. ;   et al. | 2018-10-04 |
Goblet cell replacement therapy Grant 9,895,419 - Yates-Binder , et al. February 20, 2 | 2018-02-20 |
Activators of CXCR3 for the treatment of angiopathies of the eye Grant 9,872,889 - Wells , et al. January 23, 2 | 2018-01-23 |
Goblet Cell Replacement Therapy App 20170000852 - Yates-Binder; Cecelia C. ;   et al. | 2017-01-05 |
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye App 20160361387 - Wells; Alan H. ;   et al. | 2016-12-15 |
Activators of CXCR3 for the treatment of angiopathies of the eye Grant 9,452,200 - Wells , et al. September 27, 2 | 2016-09-27 |
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye App 20160022779 - Wells; Alan H. ;   et al. | 2016-01-28 |
Activators of CXCR3 for the treatment of angiopathies of the eye Grant 9,180,167 - Wells , et al. November 10, 2 | 2015-11-10 |
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye App 20140178451 - Wells; Alan H. ;   et al. | 2014-06-26 |
Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments Grant 8,734,775 - Yates-Binder , et al. May 27, 2 | 2014-05-27 |
Chemokine Derived Peptides And Uses For Chronic Wound And Angiogenesis Inhibition Treatments App 20130053319 - Yates-Binder; Cecelia C. ;   et al. | 2013-02-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.